100 Followers on Owler
Reapplix
is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers... Read moreReapplix
is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers... Read more
News
Jul 20, 2023
Benzinga
Reapplix: Reapplix wins 2023 Frost & Sullivan's Best Practices Technology Innovation Leadership Award
Nov 07, 2022
Reapplix Vimeo Channel
Reapplix posted a video "How to prepare and apply 3C Patch on wounds" on VIMEO
Oct 27, 2022
Reapplix Vimeo Channel
Reapplix posted a video "Gunnel" on VIMEO
Sep 28, 2022
Reapplix Vimeo Channel
Reapplix posted a video "3C Patch - Living cells in wound healing" on VIMEO
Oct 06, 2021
reapplix
Press Release: Reapplix : PRESS RELEASE: REAPPLIX RECEIVES CODING AND REIMBURSEMENT DETAILS FOR 3C PATCH® IN THE US - ALL OBSTACLES REMOVED FOR COMMERCIAL EXECUTION
Apr 25, 2021
Online PR Media
Press Release: Reapplix : Sustainable Us Reimbursement for Reapplix's 3C Patch
Oct 20, 2020
EIN Presswire
Press Release: Reapplix : REAPPLIX ANNOUNCES APPOINTMENT OF RICHARD TWOMEY TO BOARD OF DIRECTORS
Jul 15, 2020
Unquote
Reapplix: Novo Holdings et al. in $20m round for Reapplix | Unquote
Jun 26, 2018
FinanzNachrichten
Reapplix: Reapplix: Positive Outcome Data of Large Randomized Controlled Trial Presented at American Diabetes Association Scientific Sessions
Apr 27, 2017
Blackbird
Press Release: Reapplix : New US FDA 510(k) clearance for expanded system including automated centrifuge
Reapplix Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Reapplix?
Reapplix News
Reapplix Press Releases
Reapplix Videos
Reapplix Headquarters
Reapplix Summary
ABOUT
Overview
Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers. Reapplix was founded in 2008. Reapplix's headquarters is located in Birkerod, Capital Region, DK 3460. Re...CEO
Reapplix's CEO, Kira Rupprecht, currently has an approval rating of 82%. Reapplix's primary competitors are Swift, Tissue Analytics, eKare, Inc. and 11 more.Website
reapplix.comCompetitors
View 14 Reapplix competitors here.Acquisitions
There have been no acquisitions found related to ReapplixInvestments
Recent investment data cannot be found related to ReapplixFrequently Asked Questions about Reapplix
When was Reapplix founded?
Reapplix was founded in 2008Who is Reapplix's CEO?
Reapplix's CEO is Kira RupprechtHow much revenue does Reapplix generate?
Reapplix generates $5.4M in revenueHow much funding does Reapplix have?
Reapplix has historically raised $25.6M in funding
Where is Reapplix's headquarters?
Reapplix's headquarters is in Birkerod Capital Region, DKHow many employees does Reapplix have?
Reapplix has 30 employeesWhat sector does Reapplix operate in?
Reapplix is in BiotechnologyWho are Reapplix's competitors?
Reapplix's top competitors are Swift, Tissue Analytics, eKare, Inc.